DAT imaging has confirmed its diagnostic accuracy in a recent paper on PPMI patients, in which the authors found a low rate of diagnostic revision (2%) in early parkinsonism when DAT imaging was utilized, as opposed to a change of 6–13% in diagnosis reported in several PD clinical trials which did not consider DAT binding deficit as an inclusionary criterion [173]. This evidence concerns the gene SLC6A3 and Parkinson disease.